Merck sues HHS over drug negotiation, claims program ‘tantamount to extortion’

United States News News

Merck sues HHS over drug negotiation, claims program ‘tantamount to extortion’
United States Latest News,United States Headlines
  • 📰 politico
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 59%

In its suit, the drug giant claims that Medicare negotiation program is unconstitutional

to block Medicare drug price negotiations, calling the program unconstitutional.

The New Jersey-based company is asking the U.S. District Court for the District of Columbia for an injunction to stop the rules from going into effect over the next several months. Merck also argued that, by participating in what it calls “sham negotiations and agreements,” its freedom of speech is being stifled.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

politico /  🏆 381. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Merck sues Biden administration over Medicare drug price negotiationsMerck sues Biden administration over Medicare drug price negotiationsIn a scathing complaint filed in federal district court, Merck excoriated the Medicare price negotiation process as a 'sham' and 'tantamount to extortion.'
Read more »

Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataCancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataAdding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a midstage trial, the companies reported on Monday.
Read more »

Moderna and Merck Cancer Vaccine Used With Keytruda Reduces Risk of Deadly Skin Cancer SpreadingModerna and Merck Cancer Vaccine Used With Keytruda Reduces Risk of Deadly Skin Cancer SpreadingMelanoma is responsible for the large majority of skin cancer deaths, according to the American Cancer Society.
Read more »

Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataCancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna dataAn experimental mRNA-based vaccine from Moderna and Merck reduced the risk that the most deadly skin cancer would spread, by 65%, compared to immunotherapy treatment alone, the companies reported on Monday.
Read more »

Merck CEO says decoupling from China would be at huge economic costMerck CEO says decoupling from China would be at huge economic costThe CEO of German technology group Merck KGaA said that unravelling trade ties with China would come at great economic costs and that she was banking on dialogue to ease tensions between Beijing and Western powers.
Read more »

To Protect Trans Health Care, We Need to Fight Bigotry — and Win Medicare for AllTo Protect Trans Health Care, We Need to Fight Bigotry — and Win Medicare for AllTrans people are up against bigoted legislation, bureaucratic red tape, and the U.S.’s cruel lack of health care access.
Read more »



Render Time: 2025-02-24 06:34:58